Marilyn Borgman

发表

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial

V. Hasselblad, P. Armstrong, J. López-Sendón, 2016, The Lancet.

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

P. Barter, J. Kastelein, C. Ballantyne, 2016, American Journal of Cardiovascular Drugs.

ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies

P. Barter, J. Kastelein, C. Ballantyne, 2012, Cardiovascular Drugs and Therapy.

Effect of two intensive statin regimens on progression of coronary disease.

Peter Libby, P. Libby, R. Erbel, 2011, The New England journal of medicine.

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.

Allen J. Taylor, C. Ballantyne, J. Kastelein, 2011, Journal of the American College of Cardiology.

Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial

J. Kastelein, J. Jukema, W. Koenig, 2018, JAMA cardiology.

Effect of Evolocumab on Coronary Plaque Composition.

W. Koenig, C. Ballantyne, J. Kastelein, 2018, Journal of the American College of Cardiology.

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.

W. Koenig, C. Ballantyne, J. Kastelein, 2016, JAMA.

Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).

W. Koenig, C. Ballantyne, J. Kastelein, 2016, American heart journal.

Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin versus AtorvastatiN)

P. Libby, R. Erbel, P. Barter, 2011, Current medical research and opinion.

Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.

S. Ellis, Marilyn Borgman, F. Resnic, 2007, The Journal of invasive cardiology.